Back to search
FDAFDA · Food and drugs·Recall number D-927-2013

Diazepam Injection, USP, 5 mg/mL, 10 mL, Multiple-dose Sterile Non-pyrogenic, Fliptop Vial, C-IV, Rx Only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-3213-12

Published September 4, 2013 · Recall initiated: August 16, 2013

Summary

FDA records drug Class II recall D-927-2013, published September 4, 2013 and initiated August 16, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 72,300 vials; Lot: Lot: 23-505-EV, Exp. 11/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility: ineffective crimp on fliptop vials that may result in leaking at the neck of the vials.

What to do

Voluntary: Firm initiated · Letter

Get an email if DIAZEPAM has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DIAZEPAM
Manufacturer
Hospira Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot: 23-505-EV, Exp. 11/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diazepam Injection, USP, 5 mg/mL, 10 mL, Multiple-dose Sterile Non-pyrogenic, Fliptop Vial, C-IV, Rx Only, Hospira, Inc., Lake Forest, IL 60045, USA, NDC 0409-3213-12 recalled?

Yes. FDA published recall D-927-2013 on September 4, 2013. Reported hazard: Lack of assurance of sterility: ineffective crimp on fliptop vials that may result in leaking at the neck of the vials.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DIAZEPAM.